Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?. Nature Reviews Clinical Oncology. 6:70-71.